急性心筋梗塞の治療におけるエベロリムス溶出コバルトクロムステントに対する早期および後期血管反応と血小板凝集試験の多施設比較 ST上昇型急性心筋梗塞の治療

基本情報

NCT ID

NCT02014753

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

100

治験依頼者名

Iwate Medical University

概要

To treat patients with acute myocardial infarction, primary percutaneous coronary intervention (PCI) will be performed with the use of an everolimus-eluting cobalt- chromium stent (everolimus-eluting stent: EES, Xience Prime, Xpedition), which is the current standard drug-eluting stent (DES). Vascular responses at the site of stent placement will be evaluated by optical coherence tomography (OCT) at 2 weeks or 3 months and at 12 months after stent placement, along with observation of changes over time in the target vessel. The relationships between OCT findings and the time course of platelet aggregation and between OCT findings and the occurrence of major cardio- cerebrovascular events will also be elucidated.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)